Logo

American Heart Association

  2
  0


Final ID: MDP1179

Techniques and Outcomes of Atrial Fibrillation Ablation in Patients with Persistent Left Superior Vena Cava

Abstract Body (Do not enter title and authors here): Introduction/Background: Persistent Left Superior Vena Cava (PLSVC) presents unique challenges for atrial fibrillation (AF) ablation due to its arrhythmogenic potential and complex anatomical variations. Understanding tailored approaches and outcomes in patients with PLSVC and AF is essential for improving procedural success and safety.

Research Questions/Hypothesis: This study aims to investigate the efficacy and outcomes of tailored ablation strategies in patients with PLSVC and AF.

Goals/Aims: To evaluate the procedural safety, acute success, and AF recurrence rate post-ablation in patients with PLSVC, and to determine the optimal ablation strategies for this population.

Methods/Approach: This retrospective cohort study included 16 patients with PLSVC who underwent 21 AF ablation procedures between August 1, 2008, and February 14, 2024, at the Hospital of the University of Pennsylvania. Procedures involved pre-ablation imaging, 3D electroanatomical mapping, pulmonary vein isolation (PVI), and targeted ablation strategies focusing on PLSVC-related triggers. The primary endpoints were procedural safety and AF recurrence post-ablation.

Results/Data: The cohort's mean age was 51.9 ± 17.9 years, 31.2% of whom were female. Triggers from the PLSVC were identified in 66.7% of procedures. Tailored ablation strategies were employed to isolate PLSVC-left atrium/coronary sinus connections or directly target the induced triggers, with a success rate of 85% in achieving isolation or targeted ablation once triggers were induced. The recurrence rate of arrhythmia post-ablation was 58.3% in the patient-based analysis and 70.6% in the procedure-based analysis. No major complications occurred.

Conclusion(s): This study highlights the significance of recognizing PLSVC as a potential source of AF triggers. The single procedure success rate is low compared to patients without PLSVC. Further studies are warranted to enhance outcomes in this challenging AF population.
  • Liao, Ting-wei Ernie  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Guandalini, Gustavo  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Nazarian, Saman  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Xu, Lingyu  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Pourmousavi Khoshknab, Mirmilad  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Peters, Carli  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Callans, David  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Marchlinski, Francis  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Schaller, Robert  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Frankel, David  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Luebbert, Jeffrey  ( University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Ting-Wei Ernie Liao: DO NOT have relevant financial relationships | Gustavo Guandalini: No Answer | Saman Nazarian: DO have relevant financial relationships ; Consultant:Biosense Webster:Active (exists now) ; Research Funding (PI or named investigator):ADAS Software:Active (exists now) ; Research Funding (PI or named investigator):Biosense Webster:Active (exists now) ; Consultant:Dyne Pharmaceuticals:Active (exists now) | Lingyu Xu: DO have relevant financial relationships ; Research Funding (PI or named investigator):American Heart Association:Active (exists now) | MirMilad Pourmousavi Khoshknab: DO NOT have relevant financial relationships | Carli Peters: No Answer | David Callans: No Answer | Francis Marchlinski: No Answer | Robert Schaller: No Answer | David Frankel: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Biosense Webster:Active (exists now) | Jeffrey Luebbert: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Down the Rabbit Hole: Atrial Fibrillation Ablation Adventures, Advancements & Adverse Events

Sunday, 11/17/2024 , 11:10AM - 12:35PM

Moderated Digital Poster Session

More abstracts on this topic:
Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction

Pohlkamp Ryan, Chidambaram Vignesh, Kumar Amudha, Ghanta Nikhila, Odueke Adetayo, Vallurupalli Srikanth, Paydak Hakan

CHD4 Interacts With TBX5 to Maintain the Gene Regulatory Network of Postnatal Atrial Cardiomyocytes

Sweat Mason, Shi Wei, Keating Erin, Ponek Anna, Conlon Frank, Pu William

More abstracts from these authors:
Risk Factors Associated with Non-Pulmonary Vein Triggers at First-Time Atrial Fibrillation Ablation

Oraii Alireza, Supple Gregory, Lin David, Dixit Sanjay, Nazarian Saman, Frankel David, Callans David, Marchlinski Francis, Chaumont Corentin, Rodriguez-queralto Oriol, Wasiak Michal, Peters Carli, Zado Erica, Hyman Matthew, Markman Timothy, Guandalini Gustavo

Quantitative Cardiac Magnetic Resonance Standardized Signal Intensity Comparison in Dilated Cardiomyopathy versus Cardiac Sarcoidosis

Liao Ting-wei Ernie, Xu Lingyu, Khoshknab Mirmilad, Mather Paul, Bravo Paco, Desjardins Benoit, Nazarian Saman

You have to be authorized to contact abstract author. Please, Login
Not Available